Your session is about to expire
← Back to Search
18F-DCFPyL Injection for Cancer
Study Summary
This trial will use a new imaging agent, 18F-DCFPyL, to detect none prostate cancer solid malignancies and schwannoma tumors using PET/CT.
- Cancer
- Schwannoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 & 3 trial • 385 Patients • NCT02981368Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could you provide a synopsis of the past research done on 18F-DCFPyL Injection?
"Currently, there are 18 studies looking into the efficacy of 18F-DCFPyL Injection. None of these trials have reached Phase 3 yet. Most experiments related to this treatment take place in Baltimore, Maryland though it is being studied at 27 different sites worldwide."
To what disorders is 18F-DCFPyL Injection typically administered?
"18F-DCFPyL Injection is typically used to reduce levels of serum prostate specific antigen (psa), but can also be beneficial in treating suspected metastasis, positron emission tomography and recurrent cases of prostate cancer."
Are participants being accepted into this research endeavor at the present time?
"Data found on clinicaltrials.gov shows that this trial is open for enrollment and has been since February 6th, 2015. The study was last revised on December 14th 2021."
Has 18F-DCFPyL Injection obtained the endorsement of the Food and Drug Administration?
"Considering the limited data on 18F-DCFPyL Injection's efficacy and safety, our team gave it a score of 1."
Does this research endeavor accept participants above the age of sixty?
"As per the trial's stipulations, participants must be aged 18 years or older and not exceed 100 to qualify for inclusion."
What is the enrolment count for this research project?
"Indeed, clinicaltrials.gov affirms that this research project is currently in search of participants. This trial was posted on February 6th 2015 and recently updated on December 14th 2021. 50 individuals are needed for the purpose of the experiment at a single centre."
Is it possible for me to participate in this research project?
"This research study is currently seeking 50 individuals with cancer in the age range of 18 to 100 years old. In order for patients to be eligible, they must possess a minimum chronologic maturity of eighteen years."
Share this study with friends
Copy Link
Messenger